Methods and systems are provided for delivering anesthetic agent to a patient. In one embodiment, a liquid anesthetic agent container includes a base region, an interior of the base region configured to hold liquid anesthetic agent, an adapter region, and a capillary force vaporizer (CFV) housed in the adapter region. The adapter region includes a coupling end configured to couple to a patient breathing circuit to supply anesthetic agent vaporized by the CFV to a patient.

An intubation infection control tent system is described. In an example implementation, an infection control tent includes a cover that forms a space in which a patient can be positioned, the cover creating an infectious barrier between the patient and an external environment, one or more support channels integrated into the cover that provide a rigid structure to the cover, and a drape skirt that connects to an edge of the cover and drapes over a portion of the patient.

A patient airway dome including an adjustable frame having a hinge such that the hinge allows the frame to adjust between an erected position to create an airway dome and a collapsed position that allows the frame to lay flat, a dome covering located over the retractable frame, a suction port which is connected to a conventional device in order to provide negative pressure to patient airway dome, and an arm access assembly operatively connected to the dome covering, wherein the arm access assembly includes an opening in the dome covering and a closure assembly located adjacent to the opening.

A system (1000) feeds substances to a patient (30) with a ventilation of the patient and with an oxygenation of the patient. The system (1000) has at least one ventilation system (1), a sedation by inhalation system (17) with a dispensing system (7), an oxygenation system (2), a breathing gas dispensing path (3), a purge gas dispensing path (4), a breathing gas connection system (5), a connection element (25) located adjacent to the patient, an oxygenation connection system (6) and a switching unit (8). The switching unit (8) is configured to distribute and to split a quantity of an inhalable substance dispensed into a gas mixture by means of the dispensing system (7) between the connection element (25) located adjacent to the patient and the oxygenation system (2). At least one control unit (9, 10, 11, 12) is configured to control the switching unit (8) and/or the system (1000).

A face mask having a positive air flow by use of an attached portable air purification unit. The device is used to filter and purify inhaled air, making it easier for individuals to comfortably wear a face mask for public health and safety. An outtake filter inhibits contaminated air from being expelled by the mask wearer. The portable air purifier is powered by means of rechargeable battery power using a USB connector, allowing static or dynamic use.

A pulmonary secretion clearing airway structure and related airway management system is disclosed that has a double lumen portion which each lumen of the double lumen portion operably secured to an airway management system so that inspiratory fluid (air/oxygen mixtures, with or without added water vapor) is delivered to the distal end of the ventilation catheter through one of the two lumens and expired inspiratory fluid, pulmonary secretions, and pulmonary fluids are removed from the patient through the other lumen. The expiratory fluid pathway preferably includes a secretion collection system for removing the pulmonary secretions and the like from the pathway, thereby improving operation and safety of the system. The airway structure can be a ventilation catheter or a supraglottic airway system such as laryngeal mask and the like.

A patient mask including a body shaped to be placed over a face of a patient and configured to prevent the passage of viruses and/or particles therethrough and at least one port configured to receive an endoscope, a surgical instrument, or both and to conform to the shape of the surgical instrument such that the port prevents the passage of viruses and/or particles therethrough.

The present disclosure provides methods of treatment of COVID-19 through pH modulation of the respiratory tract using a controlled delivery device. In some embodiments, the controlled delivery device includes an aerosolizer, a microprocessor, and a syringe. The controlled delivery device can be integrated with a humidifier or a ventilator. In some embodiments, two agents are delivered in conjunction using the controlled delivery device. In some embodiments, one agent is a physiologically compatible alkalizing agent, such as an aqueous solution of sodium bicarbonate of strength 3%-8.4% at a pH ranging from 8 to 8.6 at 20° C. In some embodiments, one agent is an anti-inflammatory agent, such as corticosteroid ciclesonide.

The Shared Manifold Ventilator uses low pressure breathing gas manifolds to interface directly with patients in a hospital ward, through solenoid valves in such a way that it achieves lower cost per patient ventilated than prior art methods while still allowing full control of the breathing cycle and oxygen concentration for each individual patient.

Provided is a filtering facepiece respirator. The respirator includes a mask body having an anterior side portion, a posterior side portion, a middle portion, a first side portion, a second side portion, a top side portion, a bottom side portion and outer edge portions. The respirator further includes a primary port positioned at the anterior middle portion of the mask body and a detachable primary port adapter which is positioned over and engages the primary port. The respirator may further include an oxygen port and oxygen port adapter and a luer port and luer port adapter.